为肺癌接受治疗的患者的心律不整:一篇综述
Maja Hawryszko1, Grzegorz Sławiński1, Bartłomiej Tomasik2
1Department of Cardiology and Heart Electrotherapy, Faculty of Medicine, Medical University of Gdansk, Smoluchowskiego 17 Street, 80-214 Gdansk, Poland.
Cancers
|December 23, 2023
概括
心脏瘤学旨在预防癌症患者的心血管疾病. 这份综述强调了肺癌患者需要进行心脏监测,因为放射治疗等治疗可能导致心律障碍.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
背景情况:
- 心脏瘤学是针对癌症患者心血管并发症的.
- 肺癌治疗方法,特别是放射治疗,可能会引起心律失常.
- 需要对与治疗有关的心律障碍进行更多的研究.
研究的目的:
- 审查肺癌患者心律失常的流行病学,发病,诊断和治疗.
- 强调这些患者定期进行心脏病监测的重要性.
- 为了突出心脏剂量测量和放射治疗引起的心脏毒性之间的联系.
主要方法:
- 对肺癌患者心律失常的现有研究进行审查.
- 分析心脏剂量测量和放射治疗之间的关系.
- 探索静态心律失常的放射性消耗 (STAR) 对于心室性心律失常.
主要成果:
- 抗癌疗法,特别是胸部放射治疗,可以导致肺癌患者的心律失常.
- 胸部照射后观察到心血管原因的死亡率增加.
- 立体心律失常的放射除显示出治疗心室性心律失常的前途.
结论:
- 在接受癌症治疗的肺癌患者中,定期进行心脏病监测是必不可少的.
- 阐明心律失常的作用对于改善患者的治疗结果至关重要.
- 加强心脏护理可以改善肺癌患者的整体治疗结果.
相关概念视频
Disturbances in Heart Rhythm
963
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
963
Mechanism of Cardiac Arrhythmias
925
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
925
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
217
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
217
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594


